Genomics in Drug Discovery ONLINE - Single-Cell CRISPR Screens for Genomics-Driven Drug Discovery

Join us for this unique 3-part webinar series, as we discover the role of genetics and genomics in modern drug discovery.

Webinar 2: Single-Cell CRISPR Screens for Genomics-Driven Drug Discovery

Tuesday 17th May at 3pm BST/4pm CET/10am EST

Targeting genetic perturbations and screening for phenotypes of interest has been made easier due to the implementation of CRISPR-based genome editing. Currently there are limited studies that benchmark methods for gene-level hits from genome-wide CRISPR screens.

This webinar will focus on the challenges of CRISPR screening and its implementation in drug discovery.

Presentations:

Applications of arrayed CRISPR screens for target identification in drug discovery -Lishu Duan, Principal Scientist I - In Vitro Pharmacology, AbbVie

The Power of Single Cell and CRISPR Screening - Stephen Hague, Managing Lead Science & Technology Advisor EMEA, 10x Genomics

A rapid CRISPR competitive assay for in vitro and in vivo discovery of potential drug targets affecting the hematopoietic system – Fredrik Wermeling, Associate Professor, Karolinska Institute

Webinar 3: Leveraging Big ‘Omics’ Data and AI in Drug Discovery

Tuesday 24th May at 3pm BST/ 4pm CET/10am EST

Join this webinar to discover new advances and the implementation of genomic data for predictive models.

Presentations:

Using Omicsfold to integrate, mine and infer new insights from multiomic big data - Shameer Khader, Senior Director (AI/ML, Data Science, Digital Health and Bioinformatics), AstraZeneca

Integrating public and commercial datasets and interpretation guidelines for genomic data analysis – Alex Joyner, Application Scientist, VarSome

Using Varsome Annotation for Disease Burden Estimation and Variants Prioritization – Star Chen, Scientist (Data Science), Agios and Sean Corbett, Scientist, Agios

Previous webinars in the series:

Webinar 1: Harnessing the Power of (Gen)omics for Drug Discovery

Tuesday 10th May at 3pm BST/4pm CET/10am EST

It has never been easier to collect vast amounts of molecular data, enabling a better understanding of complex systems and diseases. Since it was discovered that drug targets with a genetic basis are twice as likely to be approved, drug discovers have been turning to the genome in search of their latest target.

In this webinar, we explore how drug hunters are fuelling the next era of research with the power of genomics and other omics, to unlock new drugs and bring therapies closer to the patient

Presentations:

Therapeutic Discovery Platform Supported by Computational Biology - Jun Yin, Associate Director, Bioinformatics, Ferring Pharmaceuticals

Translational biomarkers: using genomics to define combination therapy in cancer patients - Tereza Vaclova, Senior Scientist, AstraZeneca

It’s a protein world: proteomics applications for drug discovery - Yann Abraham, Senior Principal Data Scientist for the AI/Genomics Initiative, Janssen